openPR Logo
Press release

Find Out How Global Neuromodulation in Epilepsy Market Helps The Research and Development Process. Find The Overview and Its Impact in the Future| Key Players: Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace

09-22-2021 03:14 PM CET | Health & Medicine

Press release from: Absolute Markets Insights

Neuromodulation in Epilepsy Market

Neuromodulation in Epilepsy Market

The Global Neuromodulation in Epilepsy Market Report is presented in a clear and concise way to help you understand market structure and dynamics. Global Neuromodulation in Epilepsy market was valued at US$ 1365.89 million in 2020 and is expected to reach US$ 3410.12+ million by 2030, growing at an estimated CAGR of 10.71% over the forecast period. Neuromodulation for epilepsy is considered to be an alternative to traditional Epilepsy Surgical approaches.

Neuromodulation in Epilepsy Market Key Players: Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others.

Request for a PDF Sample Copy of this Report here: https://www.absolutemarketsinsights.com/request_sample.php?id=276

The Market can be split into two types which is invasive and non-invasive. The U.S. Food and Drug Administration (FDA) granted approval for the use of Deep Brain Stimulation (DBS) therapy by Medtronic as a treatment option for focal epilepsy. Approximately one million people in the United States suffer from uncontrolled epilepsy. It has been duly reported that the total number of seizures decreased by 40% in people who received DBS treatment compared to 15% for those who did not receive DBS treatment. Research and development activities are being undertaken to incorporate seizure forecasting and responsive stimulation into DBS for epilepsy. A project assisted through the NIH BRAIN Initiative Public-Private Partnership Program is expected to conduct clinical research using industry-supplied cutting-edge devices.

The detailed research study provides qualitative and quantitative analysis of Neuromodulation in Epilepsy Market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Enquiry Before Buying this Premium Report at: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=276

Key Findings of the Report:
• In terms of revenue, global Neuromodulation in Epilepsy market is expected to reach USD 3410.12 million by 2030, growing at an estimated CAGR of 10.71% over the next nine years owing to the technological advancements led by researchers.
• Deep Brain Stimulation (DBS) segment has the highest penetration in 2019 as it helps the adults that have not responded to medications and those who are not meant for any other surgical procedures
• In DBS, a device is implanted, that sends signal to brain areas that are responsible for body movement. The benefits of the surgery are better sleep, more involvement in physical activity, and improved quality of life.
• Single Pulse involves placing the pulse device against the back of the head for less than a second to deliver a very brief pre-set magnetic pulse. This segment is expected to witness the highest growth over the forecast period due to safe, non-invasive and non-drug treatment.
• Asia Pacific Neuromodulation in Epilepsy market is projected to witness the highest CAGR of 11.97% over the next nine years. China dominated the market due to increased interest in neuromodulation owing to emerging valuable tools such as vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and responsive neurostimulation (RNS).
• Some of the key players operating in the Neuromodulation in Epilepsy market are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others.

Request for Customization: https://www.absolutemarketsinsights.com/request_for_customization.php?id=276

Key Market Segments of Neuromodulation in Epilepsy Market:

By Therapy Type
o Vagus Nerve Stimulation (VNS)
o Deep Brain Stimulation (DBS)

By Magnetic Stimulation Technique
o Single pulse
o Repeated pulse

By Geography
o North America
o Europe
o Asia Pacific
o Middle East & Africa
o Latin America

For More Information Click: https://www.absolutemarketsinsights.com/reports/Neuromodulation-in-Epilepsy-Market-2019-2027-276

Contact Us:

Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.
From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Find Out How Global Neuromodulation in Epilepsy Market Helps The Research and Development Process. Find The Overview and Its Impact in the Future| Key Players: Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace here

News-ID: 2402893 • Views:

More Releases from Absolute Markets Insights

Gesture Recognition Market Present Scenario and Growth Prospects 2023-2031| Google Inc., Microsoft Corporation, Apple Inc., and Qualcomm Technologies Inc.
Gesture Recognition Market Present Scenario and Growth Prospects 2023-2031| Goog …
The latest report, Global Gesture Recognition Market by Absolute Markets Insights is analyzed and researched on the basis of the comprehensive analysis of the global market. The report focuses on key market-related aspects including market segmentation, geographic segmentation, dynamics, and other market growth factors. The report contains detailed analysis of the distinct industrial growth strategies, which helps to determine the dominant segments and to know about different factors. The scope
Blockchain Identity Management Market to Reach a Valuation of USD 60 million by 2031 Research on Latest Technologies by Absolute Markets Insights
Blockchain Identity Management Market to Reach a Valuation of USD 60 million by …
Global Blockchain Identity Management Market Report is a compilation of comprehensive research studies on various aspects of the Blockchain Identity Management Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real, transparent picture of current and future situations of the global Blockchain Identity Management Market. Market participants can use this powerful tool when creating effective business plans or making important changes to their
Payment Software Market Size Revenue to Cross USD 510 million by 2031: Absolute Markets Insights
Payment Software Market Size Revenue to Cross USD 510 million by 2031: Absolute …
Global Payment Software Market was valued at USD 240 million in 2023 and is anticipated to exceed USD 510 million by 2031. The Global Payment Software Market Report studies extensive evaluation of the market growth predictions and restrictions. The strategies range from new product launches, expansions, agreements, joint ventures, partnerships, to acquisitions. This report comprises of a deep knowledge and information on what the market's definition, classifications, applications, and engagements and
Artificial Intelligence in Healthcare Market Size Worth USD 5,310.31 Million By 2031 | CAGR 48.29 %: Absolute Markets Insights
Artificial Intelligence in Healthcare Market Size Worth USD 5,310.31 Million By …
A New Market study by Absolute Markets Insights on the Global Artificial Intelligence in Healthcare Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in

All 5 Releases


More Releases for Neuromodulation

Internal Neuromodulation Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Internal Neuromodulation market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This report is
Neuromodulation Devices Market 2022 | Detailed Report
The Neuromodulation Devices research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,
Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Market Thriving Worldwide $11,717 Million By 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. For More Info, Get PDF Sample : http://bit.ly/2BciOaa Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum